Position in GANX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$34,307
+$1,521 QoQ
Shares Held
16,900
0.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 49 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthspire Advisors, LLC holds $11,785,631 across 19 Biotechnology names. GANX ranks #15 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,042 | $4,390,968 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
721,788 | $3,349,096 | |
| 3 | OCUL |
Ocular Therapeutix, Inc
|
162,960 | $1,600,267 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,138 | $565,278 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
3,540 | $307,803 | |
| 6 | MRNA |
Moderna, Inc.
|
3,953 | $276,828 | |
| 7 | RNXT |
RenovoRx, Inc.
|
252,525 | $247,474 | |
| 8 | MREO |
Mereo BioPharma Group plc
|
765,000 | $243,270 |
All Filings in GANX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,307 | 16,900 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $32,786 | 16,900 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $54,418 | 16,900 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||